Related Experiment Video
Updated: May 27, 2026
12:00
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
Published on: April 8, 2009
Learning vaccinology from viral infections
1Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA. rahmed@emory.edu
The Journal of Experimental Medicine
|November 24, 2011
Summary
This special issue honors Ralph Steinman, a Nobel laureate whose work bridged fundamental immunology discovery with clinical applications. His research advanced vaccine design and immune therapy for human diseases.
Area of Science:
- Immunology
- Translational Medicine
Background:
- This issue commemorates Ralph Steinman (1943-2011), Nobel Prize winner for discoveries in immunology.
- Steinman's work focused on translating fundamental immunological research into clinical applications for human diseases.
Purpose of the Study:
- To honor Ralph Steinman's legacy and contributions to immunology and translational medicine.
- To highlight a collaborative research effort between the Steinman and Sekaly laboratories.
Main Methods:
- The issue features a publication resulting from a collaboration between the Steinman and Sekaly laboratories.
Main Results:
- The featured paper represents a culmination of collaborative research in immunology.
Conclusions:
- Ralph Steinman's scientific contributions significantly impacted the fields of immunology, vaccine design, and immune therapy.
- His passion for translating basic science into clinical practice continues to inspire research in human immunology.
Related Concept Videos
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:28Introduction to Virus
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
00:50What are Viruses?
Overview
01:16Viral Replication: Lysogenic Cycle
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...